Phibro Animal Health Corporation (FRA:PB8)

Market Cap	1.89B +173.6%
Revenue (ttm)	1.25B +32.4%
Net Income	78.43M +376.7%
EPS	1.93 +374.0%
Shares Out	n/a
PE Ratio	24.13
Forward PE	16.82
Dividend	0.42 (0.91%)
Ex-Dividend Date	Mar 4, 2026

Volume	n/a
Average Volume	12
Open	46.40
Previous Close	45.60
Day's Range	46.40 - 46.40
52-Week Range	15.00 - 50.00
Beta	n/a
RSI	46.38
Earnings Date	May 6, 2026

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1946
• Employees: 2,475
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PB8

Financial Performance

In fiscal year 2025, Phibro Animal Health's revenue was $1.30 billion, an increase of 27.37% compared to the previous year's $1.02 billion. Earnings were $48.26 million, an increase of 1897.68%.

Financial numbers in USD